Literature DB >> 12507554

The role of ubiquitylation in signaling by growth factors: implications to cancer.

Keren Shtiegman1, Yosef Yarden.   

Abstract

Cancer cells depend on multiple, locally produced growth factors. Signaling by growth factors entails phosphorylation events, and its termination is determined primarily by endocytosis of growth factor receptor complexes. One group of growth factor receptors frequently implicated in human cancer is the ErbB family of receptor tyrosine kinases. By using ErbB as a prototype, here we review the role of protein ubiquitylation in the process that terminates signaling. Specifically, we concentrate on several adaptor proteins, including c-Cbl and Hgs, to elucidate the complexity of receptor sorting for degradation. Detailed understanding of ubiquitylation control on receptor desensitization may lead to better ways to diagnose and eradicate cancer. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507554     DOI: 10.1016/s1044-579x(02)00097-4

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  18 in total

Review 1.  Defective downregulation of receptor tyrosine kinases in cancer.

Authors:  Kristi G Bache; Thomas Slagsvold; Harald Stenmark
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

2.  SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome.

Authors:  Bao Q Vuong; Teresita L Arenzana; Brian M Showalter; Julie Losman; X Peter Chen; Justin Mostecki; Alexander S Banks; Andre Limnander; Neil Fernandez; Paul B Rothman
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 3.  Plasma membrane receptor complexes.

Authors:  José Aker; Sacco C de Vries
Journal:  Plant Physiol       Date:  2008-08       Impact factor: 8.340

4.  KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.

Authors:  Jamie L McCall; Drew Gehring; Beth K Clymer; Kurt W Fisher; Binita Das; David L Kelly; Hyunseok Kim; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

5.  Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.

Authors:  Zhongwei Cao; Xiuli Wu; Lily Yen; Colleen Sweeney; Kermit L Carraway
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

Review 6.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

7.  Comparative analyses of differentially induced T-cell receptor-mediated phosphorylation pathways in T lymphoma cells.

Authors:  Serina Ortiz; Wenhui Lee; David Smith; Stephen J Forman; Terry D Lee; Chih-Pin Liu
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

8.  Armadillo Repeat Containing 8alpha Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins.

Authors:  Koji Tomaru; Atsuhisa Ueda; Takeyuki Suzuki; Nobuaki Kobayashi; Jun Yang; Masaki Yamamoto; Mitsuhiro Takeno; Takeshi Kaneko; Yoshiaki Ishigatsubo
Journal:  Open Biochem J       Date:  2010-01-13

Review 9.  Promising new molecular targeted therapies in head and neck cancer.

Authors:  Kelly Dorsey; Mark Agulnik
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

10.  Promising newer molecular-targeted therapies in head and neck cancer.

Authors:  Lili X Wang; Mark Agulnik
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.